Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07327489 · ClinicalTrials.gov registry record

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

A clinical trial of Cancer and Colorectal Cancer, sponsored by Elephas.

Recruiting
Registry status
2,000
Enrollment target
8
Study locations

NCT07327489 is a study of Cancer and Colorectal Cancer that is actively recruiting participants, run by Elephas. The registered enrollment target is 2,000 participants, below the 3,488-participant average among 615 other Cancer trials with a reported enrollment target (43% lower). The trial reports 8 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07327489, a study of Cancer and Colorectal Cancer, is actively recruiting participants, sponsored by Elephas.

RECRUITING
Registry status
2,000 participants
Enrollment target
8
Study locations

Study Summary

This study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain tumor tissue as a normal course of their medical management or diagnostic work-up for suspected or confirmed cancer.

Conditions Studied

Cancer Colorectal Cancer Head and Neck Cancer Endometrial Cancer Bladder Cancer TNBC - Triple-Negative Breast Cancer Advanced Solid Tumors Cancer Immunotherapy MSI-H Colorectal Cancer DMMR Colorectal Cancer

Interventions

  • PROCEDURE Biopsy

Study Locations (8)

Missouri

  • Mercy Hospital - SPG - Springfield
  • Mercy Hospital - South - St Louis
  • Mercy Hospital -STL - St Louis

Texas

  • JPS Health Network - Forth Worth
  • Baylor Scott and White Biorepository - Temple

Arkansas

  • Mercy Hospital - FTS - Fort Smith

Maryland

  • Frederick Health Hospital - Frederick

Oklahoma

  • Mercy Hospital - OKC - Oklahoma City

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2025-04-14
Est. Completion 2038-04

Sponsor

Elephas

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07327489

The ClinicalTrials.gov registry entry for NCT07327489 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,488-participant average among 615 other Cancer trials with a reported enrollment target (43% lower). The listed sponsor is Elephas, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Biopsy is the first listed.

NCT07327489 reports 8 study locations spanning 5 distinct geographic areas - top geographies include Missouri, Texas, Arkansas.

Frequently Asked Questions

What is clinical trial NCT07327489 about?

NCT07327489 is a clinical study titled "Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies". This study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain tumor tissue as a normal course of their medical management or diagnostic work-up for suspected or confirmed cancer.

What is the current status of trial NCT07327489?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2025-04-14. Estimated completion is 2038-04.

What conditions does trial NCT07327489 study?

This clinical trial studies the following conditions: Cancer, Colorectal Cancer, Head and Neck Cancer, Endometrial Cancer, Bladder Cancer.

What interventions are being tested in trial NCT07327489?

The interventions under investigation include: Biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT07327489?

This trial is sponsored by Elephas, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07327489 being conducted?

This trial has 8 study locations across Arkansas, Maryland, Missouri, Oklahoma, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cancer

All registered trials for this condition

Colorectal Cancer

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.